Autoimmune Disease Diagnostics Market is Expected to Grow at a CAGR of 8.1% from 2021 to 2031

ALHAMBRA, Calif. - March 3, 2022 - PRLog -- The global autoimmune disease diagnostics market will reach $10.81 billion by 2031, growing by 8.1% annually over 2021-2031.

Download PDF Folder – https://axelreports.com/request-sample/206703

Our Autoimmune Disease Diagnostics Market exploration report delivers detailed statistics in terms of request size estimates and vaticinators for global and crucial countries. The report provides accurate exploration, deals with data with product and company-related analysis. The report focuses on trends and perceptivity impacting the assiduity, covering government policy and technological invention. The report also covers the competitive geography and presents a holistic view of the request.

Key Players:
Abbott Laboratories
Beckman Coulter, Inc.
Biomerieux SA
Bio-rad Laboratories Inc.
F. Hoffmann-la Roche Ltd.
Hemagen Diagnostics Inc.
Myriad Genetics Inc.
PerkinElmer Inc. (Euroimmun AG)
Quest Diagnostics Inc.
Siemens Healthineers Inc.
Thermo Fisher Scientific Inc.
Trinity Biotech PLC

To understand how the impact of Covid-19 is covered in this report@ https://axelreports.com/industry-analysis/global-autoimmune-disease-diagnostics-market/206703

Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Assay Kits & Consumables
• Analyzers & Instruments

Based on Test Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Autoantibodies and Immunologic Tests
  o Antinuclear Antibody Tests

o Anti-cyclic Citrullinated Peptide
o Enzyme-Linked Immunosorbent Assay (ELISA)
o Rheumatoid Factor
o Thyroid Antibody Tests
o Other Autoantibodies and Immunologic Tests

• Inflammatory Marker Tests
  o C-Reactive Protein (CRP)

o Erythrocyte Sedimentation Rate (ESR)
o Other Inflammatory Marker Tests

• Routine Laboratory Tests
  o Urinalysis

o Complete Blood Count (CBC) Tests
o Other Routine Laboratory Tests

• Other Test Types

Based on Disease Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Systemic Autoimmune Disease

o Rheumatoid Arthritis
o Systemic Lupus Erythematosus (SLE)
o Psoriasis/Psoriatic Arthritis
o Other Systemic Autoimmune Diseases

• Localized Autoimmune Disease

o Thyroiditis
o Multiple Sclerosis
o Inflammatory Bowel Disease
o Type 1 Diabetes
o Other Localized Autoimmune Diseases
Based on Gender, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Female Patients
• Male Patients

Based on Age, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• < 44
• 44 - 64
• > 64

Based on End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Hospitals
• Clinics
• Diagnostic Labs
• Other End Users